Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Go Yamamoto

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
International Journal of Hematology|December 21, 2019
Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R<sup>2</sup>) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphomaKoji Izutsu, Yosuke Minami, Noriko Fukuhara, et al.
Blood Advances|September 16, 2020
Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosisDaisuke Kaji, Yasunori Ota, Yasuharu Sato, et al.
Blood|October 11, 2011
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal typeRitsuro Suzuki, Motoko Yamaguchi, Koji Izutsu, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Hepatosplenic T-cell lymphoma with pancytopenia and massive splenomegaly]Misaki Mochida, Daisuke Kaji, Shinsuke Takagi, et al.
Transplantation and Cellular Therapy|May 29, 2026
Addition of High-Dose Cytarabine to Fludarabine, Busulfan, and Melphalan Conditioning for Cord Blood Transplantation in Adult Acute Myeloid LeukemiaKyosuke Yamaguchi, Otoya Watanabe, Takashi Mitsuki, et al.
Leukemia Research|February 6, 2026
Favorable outcomes with fludarabine, melphalan, and total-body irradiation 8-12Gy as an intensified conditioning regimen for adult allogeneic HCTTomoyo Kubo, Hisashi Yamamoto, Otoya Watanabe, et al.
Transplantation and Cellular Therapy|September 10, 2025
Optimizing MMF Dosing for GVHD Prophylaxis in Umbilical Cord Blood Transplantation: A Retrospective Study in Non-Remission Myeloid MalignanciesJotaro Yamamoto, Hisashi Yamamoto, Mika Kuno, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|March 1, 2026
CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma in a nonagenarian patientJotaro Yamamoto, Daisuke Kaji, Mika Kuno, et al.
International Journal of Hematology|March 19, 2026
Cord blood versus matched related donor transplantation in AML not in remission: role of pre-engraftment immune reactionsTatsuro Hirao, Hisashi Yamamoto, Mika Kuno, et al.
Transplantation and Cellular Therapy|May 13, 2026
Cord Blood Transplantation versus Other Donor Sources in High-risk Acute Myeloid LeukemiaTatsuro Hirao, Hisashi Yamamoto, Mika Kuno, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
International Journal of Hematology|December 21, 2019
Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R<sup>2</sup>) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphomaKoji Izutsu, Yosuke Minami, Noriko Fukuhara, et al.
Blood Advances|September 16, 2020
Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosisDaisuke Kaji, Yasunori Ota, Yasuharu Sato, et al.
Blood|October 11, 2011
Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal typeRitsuro Suzuki, Motoko Yamaguchi, Koji Izutsu, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2026
[Hepatosplenic T-cell lymphoma with pancytopenia and massive splenomegaly]Misaki Mochida, Daisuke Kaji, Shinsuke Takagi, et al.
Transplantation and Cellular Therapy|May 29, 2026
Addition of High-Dose Cytarabine to Fludarabine, Busulfan, and Melphalan Conditioning for Cord Blood Transplantation in Adult Acute Myeloid LeukemiaKyosuke Yamaguchi, Otoya Watanabe, Takashi Mitsuki, et al.
Leukemia Research|February 6, 2026
Favorable outcomes with fludarabine, melphalan, and total-body irradiation 8-12Gy as an intensified conditioning regimen for adult allogeneic HCTTomoyo Kubo, Hisashi Yamamoto, Otoya Watanabe, et al.
Transplantation and Cellular Therapy|September 10, 2025
Optimizing MMF Dosing for GVHD Prophylaxis in Umbilical Cord Blood Transplantation: A Retrospective Study in Non-Remission Myeloid MalignanciesJotaro Yamamoto, Hisashi Yamamoto, Mika Kuno, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|March 1, 2026
CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma in a nonagenarian patientJotaro Yamamoto, Daisuke Kaji, Mika Kuno, et al.
International Journal of Hematology|March 19, 2026
Cord blood versus matched related donor transplantation in AML not in remission: role of pre-engraftment immune reactionsTatsuro Hirao, Hisashi Yamamoto, Mika Kuno, et al.
Transplantation and Cellular Therapy|May 13, 2026
Cord Blood Transplantation versus Other Donor Sources in High-risk Acute Myeloid LeukemiaTatsuro Hirao, Hisashi Yamamoto, Mika Kuno, et al.
Pageof 15